Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Prevalence of ESBL Isolates of Acinetobacter baumannii Using Pulsed-Field Gel Electrophoresis

Parviz Mohajeri 1 , Abbas Farahani 2 , * , Mohammad Mehdi Feizabadi 3 , Abolfazl Davoodabadi 4 and Baharak Noroozi 2
Authors Information
1 Department of Microbiology, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Student of Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Department of Microbiology, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Pathobiology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: November 28, 2014, 16 (11); 20-23
  • Published Online: June 15, 2013
  • Article Type: Research Article
  • Received: March 18, 2013
  • Accepted: May 1, 2013

To Cite: Mohajeri P, Farahani A, Mehdi Feizabadi M, Davoodabadi A, Noroozi B. The Prevalence of ESBL Isolates of Acinetobacter baumannii Using Pulsed-Field Gel Electrophoresis, Zahedan J Res Med Sci. 2014 ; 16(11):20-23.

Copyright © 2014 Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Materials and Methods
  • 1. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003; 41(8): 3542-7[PubMed]
  • 2. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011; 55(1): 349-54[DOI][PubMed]
  • 3. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51(10): 3471-84[DOI][PubMed]
  • 4. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3): 538-82[DOI][PubMed]
  • 5. Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis. 1998; 27 Suppl 1-6[PubMed]
  • 6. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol. 1997; 35(8): 2061-7[PubMed]
  • 7. M7-A7 Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2007;
  • 8. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res. 2007; 126(1): 63-7[PubMed]
  • 9. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009; 62(5): 372-7[PubMed]
  • 10. van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect. 2007; 13 Suppl 3: 1-46[DOI][PubMed]
  • 11. Turton JF, Kaufmann ME, Warner M, Coelho J, Dijkshoorn L, van der Reijden T, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect. 2004; 58(3): 170-9[DOI][PubMed]
  • 12. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011; 3(2): 68-74[PubMed]
  • 13. Owlia P, Azimi L, Gholami A, Asghari B, Lari AR. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med. 2012; 20(3): 182-7[PubMed]
  • 14. Meric M, Willke A, Caglayan C, Toker K. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn J Infect Dis. 2005; 58(5): 297-302[PubMed]
  • 15. Cefai C, Richards J, Gould FK, McPeake P. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect. 1990; 15(2): 177-82[PubMed]
  • 16. Jazani NH, Babazadeh H, Sohrabpour M, Zartoshti M, Ghasemi-Rad M. The prevalence of extended spectrum beta-lactamases in Acinetobacter baumannii isolates from burn wounds in Iran. Inte J Microbiol. 2011; 35: 9-2
  • 17. Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, et al. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol. 2001; 50(7): 642-5[PubMed]
  • 18. Yong D, Shin JH, Kim S, Lim Y, Yum JH, Lee K, et al. High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother. 2003; 47(5): 1749-51[PubMed]
  • 19. Gouby A, Carles-Nurit MJ, Bouziges N, Bourg G, Mesnard R, Bouvet PJ. Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii. J Clin Microbiol. 1992; 30(6): 1588-91[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments